New study aims to stop nerve damage in rare blood cancer
NCT ID NCT07160270
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 21 times
Summary
This study looks at why people with Waldenström's macroglobulinemia (a rare blood cancer) often develop nerve damage, causing pain, numbness, and trouble moving. Researchers will examine 90 adults with symptoms to find the exact cause and see if early treatment can prevent lasting harm. The goal is to speed up diagnosis and improve quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL NEUROPATHIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Copenhagen Neuromuscular Center, Rigshospitalet Blegdamsvej.
RECRUITINGKøbenhavn Ø, 2100, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.